ARTICLE | Company News
Critical Path biomarker consortium
March 24, 2017 8:16 PM UTC
The Critical Path Institute launched a consortium that will aim to qualify biomarkers for Type I diabetes with FDA and EMA. The Leona M. and Harry B. Helmsley Charitable Trust, the Janssen Research & Development LLC unit of Johnson & Johnson, JDRF International and Sanofi will fund the consortium...